Atlas Trials

Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer

Clinical trial NCT00442260 · COMPLETED

Trial details

NCT number
NCT00442260
Sponsor
West Virginia University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2007-02-01
Primary completion
2008-10-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.